Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Inclusion Criteria: * Pathologically proven diagnosis of ovarian carcinoma, fallopian tube, or primary peritoneal not to include tumors of low malignant potential (all stage, grade, and histology) * First recurrence * Platinum sensitive as defined by disease free interval ≥ 6 months * Radiological evidence of recurrent disease on preoperative PET/diagnostic CT * Planned surgical secondary cytoreduction via laparotomy * \>18 years old Exclusion Criteria: * Secondary cytoreduction via laparoscopy or robotically assisted laparoscopy * Tumors of low malignant potential * Beyond first recurrence * With the exception of non-melanoma skin cancer, subjects with other invasive malignancies, who had (or have) any evidence of the other cancer present within the last 5 years, are excluded * Active infection requiring parenteral antibiotics * For subjects with diabetes mellitus, a blood sugar will be checked preoperatively and must be \<200 for participation in the study